EPISODE · Apr 24, 2026 · 1 MIN
FDA Approves Pylarify TruVu to Expand PSMA-PET Imaging Access for Prostate Cancer
from TheBrief.Health · host TheBrief.Health
Food and Drug Administration approved Pylarify TruVu, improving PSMA-PET availability and reliability, enabling better prostate cancer staging, earlier recurrence detection, and broader access to advanced diagnostic imaging.
What this episode covers
Food and Drug Administration approved Pylarify TruVu, improving PSMA-PET availability and reliability, enabling better prostate cancer staging, earlier recurrence detection, and broader access to advanced diagnostic imaging.
NOW PLAYING
FDA Approves Pylarify TruVu to Expand PSMA-PET Imaging Access for Prostate Cancer
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m